Quantum Biopharma (QNTM) News Today $15.31 -0.46 (-2.92%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$15.36 +0.05 (+0.33%) As of 08:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QNTM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Quantum Biopharma's (QNTM) Sell (E+) Rating Reaffirmed at Weiss Ratings3 hours ago | marketbeat.comQuantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTMOctober 9 at 6:00 PM | businesswire.comQNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law FirmOctober 9 at 5:40 PM | businesswire.comQuantum BioPharma offers cash reward up to $7M for market manipulation proofOctober 8 at 3:38 PM | msn.comQuantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its StockOctober 8 at 8:00 AM | globenewswire.comQuantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of ...October 3, 2025 | markets.businessinsider.comQuantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ CaseOctober 3, 2025 | globenewswire.comQuantum BioPharma receives final reports for two studies of Lucid-21-302October 2, 2025 | msn.comQuantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical TrialOctober 2, 2025 | globenewswire.comQuantum BioPharma appoints Jack Antel as clinical development advisorOctober 1, 2025 | msn.comQuantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS TrialsOctober 1, 2025 | globenewswire.comQuantum BioPharma announces Annual General, Special Meeting resultsSeptember 29, 2025 | msn.comQuantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of ShareholdersSeptember 29, 2025 | globenewswire.comQuantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025September 24, 2025 | globenewswire.comQuantum Biopharma (NASDAQ:QNTM) Stock Price Up 12.5% - What's Next?September 19, 2025 | marketbeat.comHealth Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive PerformanceSeptember 18, 2025 | globenewswire.comQuantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PTSeptember 12, 2025 | globenewswire.comQuantum BioPharma Receives BUY Rating from Kingswood Capital PartnersSeptember 10, 2025 | msn.comKingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price TargetSeptember 10, 2025 | globenewswire.comQuantum Biopharma (NASDAQ:QNTM) Shares Up 2.4% - Should You Buy?August 30, 2025 | marketbeat.comQuantum Group announces corporate updatesAugust 21, 2025 | msn.comWhy Is Quantum BioPharma In The News Today? Here’s An Important Update On Its Multiple Sclerosis Investigational DrugAugust 11, 2025 | msn.comQuantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis TrialAugust 11, 2025 | globenewswire.comQuantum BioPharma Reports Positive Phase 1 Results for MS Drug Lucid-MSAugust 9, 2025 | theglobeandmail.comQuantum BioPharma Pursues Legal Action Over Alleged Stock ManipulationAugust 9, 2025 | theglobeandmail.comQuantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis PatientsAugust 8, 2025 | globenewswire.comQuantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of DebtAugust 7, 2025 | globenewswire.comQuantum Biopharma (QNTM) to Release Earnings on WednesdayAugust 7, 2025 | marketbeat.comQuantum BioPharma stock falls after clinical trial report releaseAugust 5, 2025 | investing.comQuantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)August 5, 2025 | globenewswire.comQuantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/SpoofingAugust 4, 2025 | globenewswire.comQuantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPOJuly 31, 2025 | globenewswire.comQuantum BioPharma Makes Strategic Investment in GameStopJuly 24, 2025 | theglobeandmail.comQuantum BioPharma purchases 2,000 shares of GameStopJuly 22, 2025 | msn.comQuantum BioPharma stock falls after GameStop share purchaseJuly 22, 2025 | investing.comQuantum Biopharma (NASDAQ:QNTM) Shares Up 3.8% - Still a Buy?July 19, 2025 | marketbeat.comQuantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom - MorningstarJuly 9, 2025 | morningstar.comMQuantum BioPharma Ltd. (QNTM) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comQuantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United KingdomJuly 8, 2025 | finance.yahoo.comQNTM - Quantum BioPharma Ltd Ordinary Shares - MorningstarJuly 3, 2025 | morningstar.comMQuantum BioPharma completes $600 private placement of voting sharesJune 29, 2025 | investing.comQuantum BioPharma Announces Private Placement of 12 Class A Multiple Voting Shares at a Price of $50 Per Share - Yahoo FinanceJune 29, 2025 | finance.yahoo.comQuantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering - MorningstarJune 27, 2025 | morningstar.comMQuantum BioPharma Announces Private PlacementJune 27, 2025 | globenewswire.comBest Cannabis Stocks To Watch Today - June 26thJune 26, 2025 | marketbeat.comQuantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public OfferingJune 26, 2025 | globenewswire.comCannabis Stocks To Research - June 25thJune 25, 2025 | marketbeat.comTop Cannabis Stocks To Keep An Eye On - June 23rdJune 23, 2025 | marketbeat.comWhat is Singular Research's Estimate for QNTM Q1 Earnings?June 23, 2025 | marketbeat.comQuantum Biopharma (NASDAQ:QNTM) Upgraded at Singular ResearchJune 21, 2025 | marketbeat.com Get Quantum Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for QNTM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QNTM Media Mentions By Week QNTM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QNTM News Sentiment▼0.350.77▲Average Medical News Sentiment QNTM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QNTM Articles This Week▼82▲QNTM Articles Average Week Get the Latest News and Ratings for QNTM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Quantum Biopharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Heron Therapeutics News Atea Pharmaceuticals News Zura Bio News Tonix Pharmaceuticals News Sagimet Biosciences News Ventyx Biosciences News ProQR Therapeutics News Entrada Therapeutics News Lunai Bioworks News Cabaletta Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:QNTM) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredHave you heard of the Texas Royalty Plan?There is a backdoor way you could collect a check, four times a year, thanks to the exploding oil industry in ...Brownstone Research | SponsoredHow to Cash In on Trump’s Digital Current - Move By This ThursdayBitcoin Breakout: What Most Investors Are Missing Washington just approved more crypto legislation in 90 da...Investors Alley | SponsoredTesla’s $30 trillion pivotElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quantum Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quantum Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
